The London Technology team advised 83North and Octopus Ventures on their lead investment into Ibex Medical Analytics, an Israeli based AI-powered cancer diagnostics company, as part of a $38 million Series B funding round. aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital (the corporate venture arm of Dell Technologies) also participated in the round. The company has now raised a total of $52 million since its launch in 2016.
83North is a global venture capital firm with over $1.8 billion under management. The fund invests across all stages in exceptional entrepreneurs whose focus is to build global category-leading companies.
Octopus Ventures is one of Europe's largest and most active Venture Capital firms investing in startups in the areas of health, money, deep tech and consumer.
For additional details on this deal, please read the article in TechCrunch.